SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
January 22, 2002 (January 22, 2002)
Date of Report (Date of earliest event reported)
ALLERGAN, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 1-10269 | 95-1622442 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
||
| 2525 Dupont Drive Irvine, California |
92612 |
|||
| (Address of Principal Executive Offices) |
(Zip Code) |
(714) 246-4500
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
| Item 5. Other Events. | ||||||||
| Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events.
On January 22, 2002, Allergan, Inc., announced its intention to separate its ophthalmic surgical and contact lens care business lines into an independent publicly traded company through a tax-free distribution to Allergan shareholders. The press release dated January 22, 2002 announcing this transaction is filed as Exhibit 99.1 hereto and incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
| (c) | Exhibits. |
| 99.1 | Press release of Registrant dated January 22, 2002. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ALLERGAN, INC. | ||||||
| Date: | January 22, 2002 | By: | /S/ DOUGLAS S. INGRAM | |||
| Douglas S. Ingram Corporate Vice President, General Counsel and Secretary |
||||||
EXHIBIT INDEX
| Exhibit Number | Exhibit Description | |||||||
99.1 |
Press release of Registrant dated January 22, 2002. | |||||||